Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bronchial-Husten-Sirup (also marketed as Klosterfrau Bronchial-Husten-Sirup or Broncholind Bronchial-Husten-Sirup) is an over-the-counter herbal cough syrup developed by M.C.M. Klosterfrau Healthcare. It is formulated as a medical device containing a combination of Icelandic moss extract (Cetraria islandica), mallow blossom extract (Malva sylvestris), and honey. The syrup is primarily indicated for the relief of dry, irritating coughs (cough reflex) and mucosal irritation in the mouth and pharynx, particularly for evening or nighttime use. Upon administration, the active botanical mucilages and honey form a physical protective barrier (mucosal film) over the irritated membranes of the upper respiratory tract, shielding them from external stimuli and soothing bronchial symptoms to promote restful sleep.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bronchial-Husten-Sirup.